Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wangjun Qin, Bin Zhao, Yongguang Shang & Lei Zhang. (2021) Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance data. Expert Opinion on Drug Safety 20:9, pages 1109-1115.
Read now
Read now
Katherine Hu, Zhaowen Zhu, Meleah M Mathahs, Huy Tran, Jerry Bommer, Charles A Testa & Warren N Schmidt. (2020) Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships. Drug Design, Development and Therapy 14, pages 757-771.
Read now
Read now
Dario Akaberi, Praveen K. Chinthakindi, Amanda Båhlström, Navaneethan Palanisamy, Anja Sandström, Åke Lundkvist & Johan Lennerstrand. (2020) Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease. Journal of Biomolecular Structure and Dynamics 38:18, pages 5526-5536.
Read now
Read now
Articles from other publishers (37)
Avinash Mali, Gianluigi Franci, Carla Zannella, Annalisa Chianese, Shubaash Anthiya, Ana M. López-Estévez, Alessandra Monti, Anna De Filippis, Nunzianna Doti, María José Alonso & Massimiliano Galdiero. (2023) Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43. Pharmaceutics 15:6, pages 1621.
Crossref
Crossref
Magdalena Pachota, Renata Grzywa, Jakub Iwanejko, Aleksandra Synowiec, Dominika Iwan, Karolina Kamińska, Marcin Skoreński, Ewa Bielecka, Krzysztof Szczubiałka, Maria Nowakowska, Cameron D. Mackereth, Elżbieta Wojaczyńska, Marcin Sieńczyk & Krzysztof Pyrć. (2023) Novel inhibitors of HSV-1 protease effective in vitro and in vivo. Antiviral Research 213, pages 105604.
Crossref
Crossref
Ittipat Meewan, Sergey A. Shiryaev, Julius Kattoula, Chun-Teng Huang, Vivian Lin, Chiao-Han Chuang, Alexey V. Terskikh & Ruben Abagyan. (2023) Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in “Super-Open” Conformation. Viruses 15:5, pages 1106.
Crossref
Crossref
Isis Máximo Dantas Feitosa, Ronnie Emanuel Pereira Pinto, Matheus Mendonça Pereira, Cleide Mara Faria Soares & Álvaro Silva Lima. (2023) Extraction of protein with protease inhibitor activity from Brazilwood (Caesalpinia echinata LAM.) seeds using choline-based ionic liquids. Sustainable Chemistry and Pharmacy 31, pages 100956.
Crossref
Crossref
Anasha Kawall, Devin S. M. Lewis, Avini Sharma, Krishna Chavada, Rahul Deshmukh, Srujana Rayalam, Vicky Mody & Shashidharamurthy Taval. (2023) Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity. Frontiers in Chemistry 10.
Crossref
Crossref
Guanwei Zhou, Wei Wei Wan & Wenjing Wang. (2022) Modular Peroxidase-Based Reporters for Detecting Protease Activity and Protein Interactions with Temporal Gating. Journal of the American Chemical Society 144:50, pages 22933-22940.
Crossref
Crossref
Lydia Boike, Nathaniel J. Henning & Daniel K. Nomura. (2022) Advances in covalent drug discovery. Nature Reviews Drug Discovery 21:12, pages 881-898.
Crossref
Crossref
Yagmur Tasdemiroglu, Robert G. Gourdie & Jia-Qiang He. (2022) In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases. European Journal of Pharmacology 932, pages 175192.
Crossref
Crossref
Christian Fischer, Nynke A. Vepřek, Zisis Peitsinis, Klaus-Peter Rühmann, Chao Yang, Jessica N. Spradlin, Dustin Dovala, Daniel K. Nomura, Yingkai Zhang & Dirk Trauner. (2021) De novo Design of SARS-CoV-2 Main Protease Inhibitors. Synlett 33:05, pages 458-463.
Crossref
Crossref
H. S. Nagendra Prasad, A.P. Ananda, T.N. Lohith, P. Prabhuprasad, H.S. Jayanth, N.B. Krishnamurthy, M.A. Sridhar, L. Mallesha & P. Mallu. (2022) Design, synthesis, molecular docking and DFT computational insight on the structure of Piperazine sulfynol derivatives as a new antibacterial contender against superbugs MRSA. Journal of Molecular Structure 1247, pages 131333.
Crossref
Crossref
Saan Voss & Christoph Nitsche. (2021) Targeting the protease of West Nile virus. RSC Medicinal Chemistry 12:8, pages 1262-1272.
Crossref
Crossref
Dario Akaberi, Amanda Båhlström, Praveen K. Chinthakindi, Tomas Nyman, Anja Sandström, Josef D. Järhult, Navaneethan Palanisamy, Åke Lundkvist & Johan Lennerstrand. (2021) Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors. Antiviral Research 190, pages 105074.
Crossref
Crossref
X.M. Souto, L.S. Ramos, S.S.C. Oliveira, M.H. Branquinha & A.L.S. Santos. (2021) The serine peptidase inhibitor N-ρ-tosyl-l-phenylalanine chloromethyl ketone (TPCK) affects the cell biology of Candida haemulonii species complex. Fungal Biology 125:5, pages 378-388.
Crossref
Crossref
Donald J. AbrahamDavid A. DeGoey & Philip B. Cox. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
35
.
Rana Delshadi, Akbar Bahrami, David Julian McClements, Matthew D. Moore & Leonard Williams. (2021) Development of nanoparticle-delivery systems for antiviral agents: A review. Journal of Controlled Release 331, pages 30-44.
Crossref
Crossref
André Fischer, Manuel Sellner, Santhosh Neranjan, Martin Smieško & Markus A. Lill. (2020) Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds. International Journal of Molecular Sciences 21:10, pages 3626.
Crossref
Crossref
Saan Voss & Christoph Nitsche. (2020) Inhibitors of the Zika virus protease NS2B-NS3. Bioorganic & Medicinal Chemistry Letters 30:5, pages 126965.
Crossref
Crossref
Franck Amblard, Seema Mengshetti, Junxing Shi, Sijia Tao, Leda Bassit & Raymond F. Schinazi. 2020. The Liver. The Liver
906
914
.
Jean A. Bernatchez, Lana T. Tran, Jerry Li, Yepeng Luan, Jair L. Siqueira-Neto & Rongshi Li. (2019) Drugs for the Treatment of Zika Virus Infection. Journal of Medicinal Chemistry 63:2, pages 470-489.
Crossref
Crossref
Attapol Kamthong, Phenbunya Boonyalekha, Jeerapond Leelawattanachai & Waraho-Zhmayev Dujduan. (2020) Application of the Synthetic Escherichia coli’s Twin-Arginine Translocation Pathway for the Detection of Intracellular Antibodies against Hepatitis C Viral Protease. International Journal of Bioscience, Biochemistry and Bioinformatics 10:1, pages 49-57.
Crossref
Crossref
Elisabete Andrade, Daniele Rocha, Marcela Fontana-Maurell, Elaine Costa, Marisa Ribeiro, Daniela Tupy de Godoy, Antonio G.P. Ferreira, Amilcar Tanuri, Rodrigo Brindeiro & Patrícia Alvarez. (2020) Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil. Genetics and Molecular Biology 43:1.
Crossref
Crossref
Michael Houghton. (2019) Hepatitis C Virus: 30 Years after Its Discovery. Cold Spring Harbor Perspectives in Medicine 9:12, pages a037069.
Crossref
Crossref
Lize Cuypers, Marijn Thijssen, Arash Shakibzadeh, Ward Deboutte, Jamal Sarvari, Farzaneh Sabahi, Mehrdad Ravanshad & Mahmoud Reza Pourkarim. (2019) Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran. Infection, Genetics and Evolution 75, pages 103966.
Crossref
Crossref
Xiangyi Jiang, Ji Yu, Zhongxia Zhou, Jacob Kongsted, Yuning Song, Christophe Pannecouque, Erik De Clercq, Dongwei Kang, Vasanthanathan Poongavanam, Xinyong Liu & Peng Zhan. (2019) Molecular design opportunities presented by solvent‐exposed regions of target proteins. Medicinal Research Reviews 39:6, pages 2194-2238.
Crossref
Crossref
Wu Liu, Mehmet U. Caglar, Zhangming MaoAndrew WoodmanJamie J. ArnoldClaus O. Wilke & Craig E. Cameron. (2019) More than efficacy revealed by single-cell analysis of antiviral therapeutics. Science Advances 5:10.
Crossref
Crossref
Glenna Wink Foight, Zhizhi Wang, Cindy T. Wei, Per Jr Greisen, Katrina M. Warner, Daniel Cunningham-Bryant, Keunwan Park, T. J. Brunette, William Sheffler, David Baker & Dustin J. Maly. (2019) Multi-input chemical control of protein dimerization for programming graded cellular responses. Nature Biotechnology 37:10, pages 1209-1216.
Crossref
Crossref
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal & Christopher J. O’Donnell. (2019) Synthetic Approaches to the New Drugs Approved During 2017. Journal of Medicinal Chemistry 62:16, pages 7340-7382.
Crossref
Crossref
Ali KÜÇÜK & Yakup YILDIRIM. (2019) Antiviral İlaçlarAntiviral Drug. Etlik Veteriner Mikrobiyoloji Dergisi 30:1, pages 100-108.
Crossref
Crossref
Jirayu Kammarabutr, Panupong Mahalapbutr, Bodee Nutho, Nawee Kungwan & Thanyada Rungrotmongkol. (2019) Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation. Journal of Molecular Graphics and Modelling 89, pages 122-130.
Crossref
Crossref
Joseph M Luna, Mohsan Saeed & Charles M Rice. (2019) Taming a beast: lessons from the domestication of hepatitis C virus. Current Opinion in Virology 35, pages 27-34.
Crossref
Crossref
Thuy Van Lam van, Teodora Ivanova, Kornelia Hardes, Miriam Ruth Heindl, Rory E. Morty, Eva Böttcher‐Friebertshäuser, Iris Lindberg, Manuel E. Than, Sven O. Dahms & Torsten Steinmetzer. (2019) Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin. ChemMedChem 14:6, pages 673-685.
Crossref
Crossref
Georgia Koutsoumpli, Peng Peng Ip, Ilona Schepel, Baukje Nynke Hoogeboom, Annemarie Boerma & Toos Daemen. (2019) Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?. Therapeutic Advances in Vaccines and Immunotherapy 7, pages 251513551987467.
Crossref
Crossref
Saleh A. Alqahtani & Mark S. Sulkowski. 2019. HCV: The Journey from Discovery to a Cure. HCV: The Journey from Discovery to a Cure
97
113
.
Song Meng, Gong-Li Tang & Hai-Xue Pan. (2018) Enzymatic Formation of Oxygen-Containing Heterocycles in Natural Product Biosynthesis. ChemBioChem 19:19, pages 2002-2022.
Crossref
Crossref
Francesca Ceccherini-Silberstein, Valeria Cento, Velia Chiara Di Maio, Carlo Federico Perno & Antonio Craxì. (2018) Viral resistance in HCV infection. Current Opinion in Virology 32, pages 115-127.
Crossref
Crossref
Marta M Gaglia & Karl Munger. (2018) More than just oncogenes: mechanisms of tumorigenesis by human viruses. Current Opinion in Virology 32, pages 48-59.
Crossref
Crossref
Fabián Aldunate, Natalia Echeverría, Daniela Chiodi, Pablo López, Adriana Sánchez-Cicerón, Alvaro Fajardo, Martín Soñora, Juan Cristina, Nelia Hernández & Pilar Moreno. (2018) Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients. Disease Markers 2018, pages 1-9.
Crossref
Crossref